Adicet Bio, Inc. Operating Leases, Future Minimum Payments Due, Next Twelve Months
Adicet Bio, Inc. (ACET) had Operating Leases, Future Minimum Payments Due, Next Twelve Months of $5.01 million as of 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent · last filed 2023-11-08
- 2023-09-30: Operating Leases, Future Minimum Payments Due, Next Twelve Months $5.01M.
- 2023-06-30: Operating Leases, Future Minimum Payments Due, Next Twelve Months $5.01M.
- 2023-03-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $5.00M.
- 2022-09-30: Operating Leases, Future Minimum Payments Due, Next Twelve Months $4.32M.
| Period end | Operating Leases, Future Minimum Payments Due, Next Twelve Months | Operating Leases, Future Minimum Payments Due, Next Twelve Months as first filed |
|---|---|---|
| 2023-09-30 | $5.01M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $5.01M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $5.00M 10-Q · filed 2023-05-09 | |
| 2022-09-30 | $4.32M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $4.30M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $3.43M 10-Q · filed 2022-05-12 | |
| 2021-09-30 | $2.93M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $2.93M 10-Q · filed 2021-08-12 | |
| 2020-09-30 | $4.12M 10-Q · filed 2020-11-05 | |
| 2019-12-31 | $2.72M 10-K · filed 2021-03-12 | $594.00K 10-K · filed 2020-03-12 |
| 2018-12-31 | $231.00K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |